nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexamethasone—NOS2—psoriasis	0.055	1	CbGaD
Dexamethasone—Corticosteroid Hormone Receptor Agonists—Fluocinonide—psoriasis	0.0489	0.223	CiPCiCtD
Dexamethasone—Corticosteroid Hormone Receptor Agonists—Fluocinolone Acetonide—psoriasis	0.0489	0.223	CiPCiCtD
Dexamethasone—Clobetasol propionate—psoriasis	0.0343	0.194	CrCtD
Dexamethasone—psoriatic arthritis—psoriasis	0.0339	0.234	CtDrD
Dexamethasone—atopic dermatitis—psoriasis	0.031	0.214	CtDrD
Dexamethasone—Corticosteroid Hormone Receptor Agonists—Hydrocortisone—psoriasis	0.0281	0.128	CiPCiCtD
Dexamethasone—brain cancer—Triamcinolone—psoriasis	0.028	0.245	CpDpCtD
Dexamethasone—ankylosing spondylitis—psoriasis	0.0279	0.193	CtDrD
Dexamethasone—Beclomethasone—psoriasis	0.0275	0.155	CrCtD
Dexamethasone—Fluocinonide—psoriasis	0.0275	0.155	CrCtD
Dexamethasone—Fluocinolone Acetonide—psoriasis	0.0267	0.151	CrCtD
Dexamethasone—systemic lupus erythematosus—psoriasis	0.0267	0.184	CtDrD
Dexamethasone—rheumatoid arthritis—psoriasis	0.0252	0.174	CtDrD
Dexamethasone—Corticosteroid Hormone Receptor Agonists—Betamethasone—psoriasis	0.0247	0.113	CiPCiCtD
Dexamethasone—Corticosteroid Hormone Receptor Agonists—Triamcinolone—psoriasis	0.0239	0.109	CiPCiCtD
Dexamethasone—Corticosteroid Hormone Receptor Agonists—Prednisolone—psoriasis	0.0231	0.105	CiPCiCtD
Dexamethasone—Corticosteroid Hormone Receptor Agonists—Prednisone—psoriasis	0.0218	0.0995	CiPCiCtD
Dexamethasone—kidney cancer—Hydrocortisone—psoriasis	0.018	0.158	CpDpCtD
Dexamethasone—colon cancer—Betamethasone—psoriasis	0.0152	0.133	CpDpCtD
Dexamethasone—brain cancer—Betamethasone—psoriasis	0.0152	0.133	CpDpCtD
Dexamethasone—Hydrocortisone—psoriasis	0.0135	0.0761	CrCtD
Dexamethasone—prostate cancer—Hydrocortisone—psoriasis	0.013	0.114	CpDpCtD
Dexamethasone—Betamethasone—psoriasis	0.0125	0.0707	CrCtD
Dexamethasone—Triamcinolone—psoriasis	0.0123	0.0691	CrCtD
Dexamethasone—Prednisone—psoriasis	0.0116	0.0656	CrCtD
Dexamethasone—ANXA1—Hydrocortisone—psoriasis	0.0116	0.108	CbGbCtD
Dexamethasone—Prednisolone—psoriasis	0.0113	0.064	CrCtD
Dexamethasone—kidney cancer—Betamethasone—psoriasis	0.011	0.0965	CpDpCtD
Dexamethasone—PLA2G1B—Betamethasone—psoriasis	0.00987	0.0916	CbGbCtD
Dexamethasone—prostate cancer—Betamethasone—psoriasis	0.00796	0.0698	CpDpCtD
Dexamethasone—NR3C1—Clobetasol propionate—psoriasis	0.0056	0.052	CbGbCtD
Dexamethasone—breast cancer—Betamethasone—psoriasis	0.00559	0.049	CpDpCtD
Dexamethasone—CYP11A1—Cholecalciferol—psoriasis	0.00461	0.0428	CbGbCtD
Dexamethasone—NR3C2—Betamethasone—psoriasis	0.00439	0.0408	CbGbCtD
Dexamethasone—NR3C2—Prednisolone—psoriasis	0.00433	0.0403	CbGbCtD
Dexamethasone—NR3C1—Fluocinonide—psoriasis	0.00424	0.0394	CbGbCtD
Dexamethasone—NR3C1—Beclomethasone—psoriasis	0.00424	0.0394	CbGbCtD
Dexamethasone—NR3C1—Fluocinolone Acetonide—psoriasis	0.00424	0.0394	CbGbCtD
Dexamethasone—CYP1A1—Clobetasol propionate—psoriasis	0.00334	0.031	CbGbCtD
Dexamethasone—PGR—Betamethasone—psoriasis	0.00284	0.0263	CbGbCtD
Dexamethasone—CYP2A6—Methoxsalen—psoriasis	0.00205	0.0191	CbGbCtD
Dexamethasone—CYP1A1—Methoxsalen—psoriasis	0.00175	0.0163	CbGbCtD
Dexamethasone—ABCB11—Cyclosporine—psoriasis	0.00174	0.0162	CbGbCtD
Dexamethasone—NR3C1—Triamcinolone—psoriasis	0.00169	0.0157	CbGbCtD
Dexamethasone—CYP19A1—Betamethasone—psoriasis	0.0016	0.0148	CbGbCtD
Dexamethasone—CYP2C8—Tazarotene—psoriasis	0.00157	0.0146	CbGbCtD
Dexamethasone—CYP3A5—Beclomethasone—psoriasis	0.00152	0.0141	CbGbCtD
Dexamethasone—NR3C1—Betamethasone—psoriasis	0.00145	0.0135	CbGbCtD
Dexamethasone—NR3C1—Prednisolone—psoriasis	0.00143	0.0133	CbGbCtD
Dexamethasone—NR3C1—Hydrocortisone—psoriasis	0.00136	0.0126	CbGbCtD
Dexamethasone—NR3C1—Prednisone—psoriasis	0.00135	0.0125	CbGbCtD
Dexamethasone—SLCO1A2—Prednisolone—psoriasis	0.00123	0.0114	CbGbCtD
Dexamethasone—Fluticasone furoate—Clobetasol propionate—psoriasis	0.00121	0.00954	CrCrCtD
Dexamethasone—ABCC2—Mycophenolate mofetil—psoriasis	0.00121	0.0112	CbGbCtD
Dexamethasone—PTGS2—Triamcinolone—psoriasis	0.00119	0.0111	CbGbCtD
Dexamethasone—SLCO1A2—Hydrocortisone—psoriasis	0.00117	0.0108	CbGbCtD
Dexamethasone—SLCO1A2—Prednisone—psoriasis	0.00116	0.0108	CbGbCtD
Dexamethasone—CYP1A1—Cholecalciferol—psoriasis	0.00116	0.0108	CbGbCtD
Dexamethasone—SLCO1A2—Cyclosporine—psoriasis	0.0011	0.0102	CbGbCtD
Dexamethasone—Flumethasone Pivalate—Clobetasol propionate—psoriasis	0.00109	0.00857	CrCrCtD
Dexamethasone—ABCG2—Mycophenolate mofetil—psoriasis	0.00109	0.0101	CbGbCtD
Dexamethasone—Halobetasol Propionate—Clobetasol propionate—psoriasis	0.00106	0.0083	CrCrCtD
Dexamethasone—Fluticasone Propionate—Clobetasol propionate—psoriasis	0.00106	0.0083	CrCrCtD
Dexamethasone—Difluprednate—Clobetasol propionate—psoriasis	0.00106	0.0083	CrCrCtD
Dexamethasone—PTGS2—Betamethasone—psoriasis	0.00102	0.0095	CbGbCtD
Dexamethasone—CYP2A6—Prednisolone—psoriasis	0.000997	0.00927	CbGbCtD
Dexamethasone—Prednicarbate—Clobetasol propionate—psoriasis	0.000993	0.0078	CrCrCtD
Dexamethasone—Fluocinonide—Clobetasol propionate—psoriasis	0.000993	0.0078	CrCrCtD
Dexamethasone—Beclomethasone—Clobetasol propionate—psoriasis	0.000993	0.0078	CrCrCtD
Dexamethasone—Clocortolone—Clobetasol propionate—psoriasis	0.000993	0.0078	CrCrCtD
Dexamethasone—Fluticasone furoate—Beclomethasone—psoriasis	0.000972	0.00764	CrCrCtD
Dexamethasone—Fluticasone furoate—Fluocinonide—psoriasis	0.000972	0.00764	CrCrCtD
Dexamethasone—Fluticasone furoate—Fluocinolone Acetonide—psoriasis	0.000945	0.00743	CrCrCtD
Dexamethasone—Alclometasone—Clobetasol propionate—psoriasis	0.000938	0.00737	CrCrCtD
Dexamethasone—Fluocinolone Acetonide—Clobetasol propionate—psoriasis	0.000938	0.00737	CrCrCtD
Dexamethasone—ABCC2—Cyclosporine—psoriasis	0.000914	0.00849	CbGbCtD
Dexamethasone—Amcinonide—Clobetasol propionate—psoriasis	0.000913	0.00717	CrCrCtD
Dexamethasone—Fluoxymesterone—Clobetasol propionate—psoriasis	0.000913	0.00717	CrCrCtD
Dexamethasone—Budesonide—Clobetasol propionate—psoriasis	0.000913	0.00717	CrCrCtD
Dexamethasone—Flurandrenolide—Fluocinonide—psoriasis	0.000904	0.0071	CrCrCtD
Dexamethasone—Diflorasone—Clobetasol propionate—psoriasis	0.000889	0.00699	CrCrCtD
Dexamethasone—Fludrocortisone—Clobetasol propionate—psoriasis	0.000889	0.00699	CrCrCtD
Dexamethasone—Desonide—Clobetasol propionate—psoriasis	0.000889	0.00699	CrCrCtD
Dexamethasone—Prednisone—Clobetasol propionate—psoriasis	0.000889	0.00699	CrCrCtD
Dexamethasone—CYP2B6—Cholecalciferol—psoriasis	0.000885	0.00822	CbGbCtD
Dexamethasone—Flurandrenolide—Fluocinolone Acetonide—psoriasis	0.000879	0.0069	CrCrCtD
Dexamethasone—ABCG2—Hydrocortisone—psoriasis	0.000875	0.00813	CbGbCtD
Dexamethasone—Flumethasone Pivalate—Beclomethasone—psoriasis	0.000874	0.00687	CrCrCtD
Dexamethasone—Flumethasone Pivalate—Fluocinonide—psoriasis	0.000874	0.00687	CrCrCtD
Dexamethasone—Paramethasone—Clobetasol propionate—psoriasis	0.000867	0.00681	CrCrCtD
Dexamethasone—Flumethasone Pivalate—Fluocinolone Acetonide—psoriasis	0.000849	0.00667	CrCrCtD
Dexamethasone—Fluticasone Propionate—Fluocinonide—psoriasis	0.000846	0.00665	CrCrCtD
Dexamethasone—Difluprednate—Fluocinonide—psoriasis	0.000846	0.00665	CrCrCtD
Dexamethasone—Halobetasol Propionate—Beclomethasone—psoriasis	0.000846	0.00665	CrCrCtD
Dexamethasone—Fluticasone Propionate—Beclomethasone—psoriasis	0.000846	0.00665	CrCrCtD
Dexamethasone—Halobetasol Propionate—Fluocinonide—psoriasis	0.000846	0.00665	CrCrCtD
Dexamethasone—Difluprednate—Beclomethasone—psoriasis	0.000846	0.00665	CrCrCtD
Dexamethasone—Desoximetasone—Clobetasol propionate—psoriasis	0.000846	0.00665	CrCrCtD
Dexamethasone—ABCG2—Cyclosporine—psoriasis	0.000827	0.00768	CbGbCtD
Dexamethasone—Mometasone—Clobetasol propionate—psoriasis	0.000826	0.00649	CrCrCtD
Dexamethasone—Triamcinolone—Clobetasol propionate—psoriasis	0.000826	0.00649	CrCrCtD
Dexamethasone—Loteprednol—Clobetasol propionate—psoriasis	0.000826	0.00649	CrCrCtD
Dexamethasone—Fluprednidene Acetate—Clobetasol propionate—psoriasis	0.000826	0.00649	CrCrCtD
Dexamethasone—Fluorometholone—Clobetasol propionate—psoriasis	0.000826	0.00649	CrCrCtD
Dexamethasone—Fluticasone Propionate—Fluocinolone Acetonide—psoriasis	0.000822	0.00646	CrCrCtD
Dexamethasone—Difluprednate—Fluocinolone Acetonide—psoriasis	0.000822	0.00646	CrCrCtD
Dexamethasone—Halobetasol Propionate—Fluocinolone Acetonide—psoriasis	0.000822	0.00646	CrCrCtD
Dexamethasone—Rimexolone—Clobetasol propionate—psoriasis	0.000807	0.00634	CrCrCtD
Dexamethasone—Betamethasone—Clobetasol propionate—psoriasis	0.000807	0.00634	CrCrCtD
Dexamethasone—Clocortolone—Fluocinonide—psoriasis	0.000795	0.00625	CrCrCtD
Dexamethasone—Fluocinonide—Beclomethasone—psoriasis	0.000795	0.00625	CrCrCtD
Dexamethasone—Clocortolone—Beclomethasone—psoriasis	0.000795	0.00625	CrCrCtD
Dexamethasone—Prednicarbate—Beclomethasone—psoriasis	0.000795	0.00625	CrCrCtD
Dexamethasone—Beclomethasone—Fluocinonide—psoriasis	0.000795	0.00625	CrCrCtD
Dexamethasone—Fluocinonide—Fluocinolone Acetonide—psoriasis	0.000773	0.00607	CrCrCtD
Dexamethasone—Beclomethasone—Fluocinolone Acetonide—psoriasis	0.000773	0.00607	CrCrCtD
Dexamethasone—Clocortolone—Fluocinolone Acetonide—psoriasis	0.000773	0.00607	CrCrCtD
Dexamethasone—Fluocortolone—Fluocinonide—psoriasis	0.000773	0.00607	CrCrCtD
Dexamethasone—Methylprednisolone—Clobetasol propionate—psoriasis	0.000772	0.00606	CrCrCtD
Dexamethasone—Prednisolone—Clobetasol propionate—psoriasis	0.000756	0.00594	CrCrCtD
Dexamethasone—Fluocinolone Acetonide—Beclomethasone—psoriasis	0.000751	0.0059	CrCrCtD
Dexamethasone—Alclometasone—Beclomethasone—psoriasis	0.000751	0.0059	CrCrCtD
Dexamethasone—Fluocinolone Acetonide—Fluocinonide—psoriasis	0.000751	0.0059	CrCrCtD
Dexamethasone—Fluocortolone—Fluocinolone Acetonide—psoriasis	0.000751	0.0059	CrCrCtD
Dexamethasone—Amcinonide—Beclomethasone—psoriasis	0.000731	0.00574	CrCrCtD
Dexamethasone—Budesonide—Beclomethasone—psoriasis	0.000731	0.00574	CrCrCtD
Dexamethasone—Amcinonide—Fluocinonide—psoriasis	0.000731	0.00574	CrCrCtD
Dexamethasone—Budesonide—Fluocinonide—psoriasis	0.000731	0.00574	CrCrCtD
Dexamethasone—Alclometasone—Fluocinolone Acetonide—psoriasis	0.00073	0.00574	CrCrCtD
Dexamethasone—Clobetasol propionate—Beclomethasone—psoriasis	0.000712	0.0056	CrCrCtD
Dexamethasone—Flunisolide—Fluocinonide—psoriasis	0.000712	0.0056	CrCrCtD
Dexamethasone—Diflorasone—Fluocinonide—psoriasis	0.000712	0.0056	CrCrCtD
Dexamethasone—Diflorasone—Beclomethasone—psoriasis	0.000712	0.0056	CrCrCtD
Dexamethasone—Desonide—Fluocinonide—psoriasis	0.000712	0.0056	CrCrCtD
Dexamethasone—Clobetasol propionate—Fluocinonide—psoriasis	0.000712	0.0056	CrCrCtD
Dexamethasone—Desonide—Beclomethasone—psoriasis	0.000712	0.0056	CrCrCtD
Dexamethasone—Amcinonide—Fluocinolone Acetonide—psoriasis	0.00071	0.00558	CrCrCtD
Dexamethasone—Budesonide—Fluocinolone Acetonide—psoriasis	0.00071	0.00558	CrCrCtD
Dexamethasone—CYP2D6—Hydroxyurea—psoriasis	0.000705	0.00655	CbGbCtD
Dexamethasone—Paramethasone—Fluocinonide—psoriasis	0.000694	0.00546	CrCrCtD
Dexamethasone—Clobetasol propionate—Fluocinolone Acetonide—psoriasis	0.000692	0.00544	CrCrCtD
Dexamethasone—Desonide—Fluocinolone Acetonide—psoriasis	0.000692	0.00544	CrCrCtD
Dexamethasone—Fludrocortisone—Fluocinolone Acetonide—psoriasis	0.000692	0.00544	CrCrCtD
Dexamethasone—Flunisolide—Fluocinolone Acetonide—psoriasis	0.000692	0.00544	CrCrCtD
Dexamethasone—Diflorasone—Fluocinolone Acetonide—psoriasis	0.000692	0.00544	CrCrCtD
Dexamethasone—Desoximetasone—Beclomethasone—psoriasis	0.000677	0.00532	CrCrCtD
Dexamethasone—Desoximetasone—Fluocinonide—psoriasis	0.000677	0.00532	CrCrCtD
Dexamethasone—Paramethasone—Fluocinolone Acetonide—psoriasis	0.000675	0.0053	CrCrCtD
Dexamethasone—CYP2C8—Cholecalciferol—psoriasis	0.00067	0.00622	CbGbCtD
Dexamethasone—Loteprednol—Beclomethasone—psoriasis	0.000661	0.0052	CrCrCtD
Dexamethasone—Fluorometholone—Fluocinonide—psoriasis	0.000661	0.0052	CrCrCtD
Dexamethasone—Fluprednidene Acetate—Beclomethasone—psoriasis	0.000661	0.0052	CrCrCtD
Dexamethasone—Fluprednidene Acetate—Fluocinonide—psoriasis	0.000661	0.0052	CrCrCtD
Dexamethasone—Mometasone—Beclomethasone—psoriasis	0.000661	0.0052	CrCrCtD
Dexamethasone—Triamcinolone—Beclomethasone—psoriasis	0.000661	0.0052	CrCrCtD
Dexamethasone—Mometasone—Fluocinonide—psoriasis	0.000661	0.0052	CrCrCtD
Dexamethasone—Triamcinolone—Fluocinonide—psoriasis	0.000661	0.0052	CrCrCtD
Dexamethasone—Fluorometholone—Beclomethasone—psoriasis	0.000661	0.0052	CrCrCtD
Dexamethasone—Desoximetasone—Fluocinolone Acetonide—psoriasis	0.000658	0.00517	CrCrCtD
Dexamethasone—CYP3A7—Hydrocortisone—psoriasis	0.000646	0.006	CbGbCtD
Dexamethasone—CYP3A7-CYP3A51P—Hydrocortisone—psoriasis	0.000646	0.006	CbGbCtD
Dexamethasone—Rimexolone—Fluocinonide—psoriasis	0.000646	0.00508	CrCrCtD
Dexamethasone—Betamethasone—Beclomethasone—psoriasis	0.000646	0.00508	CrCrCtD
Dexamethasone—Rimexolone—Beclomethasone—psoriasis	0.000646	0.00508	CrCrCtD
Dexamethasone—Betamethasone—Fluocinonide—psoriasis	0.000646	0.00508	CrCrCtD
Dexamethasone—Mometasone—Fluocinolone Acetonide—psoriasis	0.000643	0.00505	CrCrCtD
Dexamethasone—Triamcinolone—Fluocinolone Acetonide—psoriasis	0.000643	0.00505	CrCrCtD
Dexamethasone—Fluorometholone—Fluocinolone Acetonide—psoriasis	0.000643	0.00505	CrCrCtD
Dexamethasone—Fluprednidene Acetate—Fluocinolone Acetonide—psoriasis	0.000643	0.00505	CrCrCtD
Dexamethasone—Rimexolone—Fluocinolone Acetonide—psoriasis	0.000628	0.00493	CrCrCtD
Dexamethasone—Betamethasone—Fluocinolone Acetonide—psoriasis	0.000628	0.00493	CrCrCtD
Dexamethasone—Methylprednisolone—Fluocinonide—psoriasis	0.000618	0.00486	CrCrCtD
Dexamethasone—CYP3A7-CYP3A51P—Cyclosporine—psoriasis	0.00061	0.00567	CbGbCtD
Dexamethasone—CYP3A7—Cyclosporine—psoriasis	0.00061	0.00567	CbGbCtD
Dexamethasone—Prednisolone—Beclomethasone—psoriasis	0.000605	0.00475	CrCrCtD
Dexamethasone—CYP3A5—Mycophenolate mofetil—psoriasis	0.000604	0.00561	CbGbCtD
Dexamethasone—Methylprednisolone—Fluocinolone Acetonide—psoriasis	0.000601	0.00472	CrCrCtD
Dexamethasone—Prednisolone—Fluocinolone Acetonide—psoriasis	0.000588	0.00462	CrCrCtD
Dexamethasone—SLCO1A2—Methotrexate—psoriasis	0.000584	0.00542	CbGbCtD
Dexamethasone—CYP2C8—Mycophenolate mofetil—psoriasis	0.000581	0.0054	CbGbCtD
Dexamethasone—CYP2C19—Cholecalciferol—psoriasis	0.000562	0.00522	CbGbCtD
Dexamethasone—CYP3A4—Calcitriol—psoriasis	0.000528	0.0049	CbGbCtD
Dexamethasone—CYP3A5—Hydrocortisone—psoriasis	0.000485	0.0045	CbGbCtD
Dexamethasone—ABCC2—Methotrexate—psoriasis	0.000484	0.00449	CbGbCtD
Dexamethasone—CYP2C9—Cholecalciferol—psoriasis	0.000467	0.00434	CbGbCtD
Dexamethasone—CYP2C8—Hydrocortisone—psoriasis	0.000466	0.00433	CbGbCtD
Dexamethasone—CYP3A5—Cyclosporine—psoriasis	0.000458	0.00425	CbGbCtD
Dexamethasone—Flurandrenolide—Hydrocortisone—psoriasis	0.000444	0.00349	CrCrCtD
Dexamethasone—Fluticasone furoate—Betamethasone—psoriasis	0.000443	0.00348	CrCrCtD
Dexamethasone—CYP2C8—Cyclosporine—psoriasis	0.00044	0.00409	CbGbCtD
Dexamethasone—ABCG2—Methotrexate—psoriasis	0.000437	0.00406	CbGbCtD
Dexamethasone—Fluticasone furoate—Triamcinolone—psoriasis	0.000433	0.0034	CrCrCtD
Dexamethasone—CYP2D6—Cholecalciferol—psoriasis	0.000427	0.00397	CbGbCtD
Dexamethasone—Flurandrenolide—Betamethasone—psoriasis	0.000412	0.00324	CrCrCtD
Dexamethasone—CYP3A4—Methoxsalen—psoriasis	0.00041	0.00381	CbGbCtD
Dexamethasone—Flumethasone Pivalate—Betamethasone—psoriasis	0.000398	0.00313	CrCrCtD
Dexamethasone—ABCB1—Mycophenolate mofetil—psoriasis	0.000393	0.00365	CbGbCtD
Dexamethasone—Prednicarbate—Hydrocortisone—psoriasis	0.00039	0.00307	CrCrCtD
Dexamethasone—CYP2C19—Prednisone—psoriasis	0.00039	0.00362	CbGbCtD
Dexamethasone—Flumethasone Pivalate—Triamcinolone—psoriasis	0.000389	0.00306	CrCrCtD
Dexamethasone—Halobetasol Propionate—Betamethasone—psoriasis	0.000386	0.00303	CrCrCtD
Dexamethasone—Difluprednate—Betamethasone—psoriasis	0.000386	0.00303	CrCrCtD
Dexamethasone—Fluticasone Propionate—Betamethasone—psoriasis	0.000386	0.00303	CrCrCtD
Dexamethasone—Halobetasol Propionate—Triamcinolone—psoriasis	0.000377	0.00296	CrCrCtD
Dexamethasone—Difluprednate—Triamcinolone—psoriasis	0.000377	0.00296	CrCrCtD
Dexamethasone—Fluticasone Propionate—Triamcinolone—psoriasis	0.000377	0.00296	CrCrCtD
Dexamethasone—Flurandrenolide—Prednisolone—psoriasis	0.000373	0.00293	CrCrCtD
Dexamethasone—CYP2C19—Cyclosporine—psoriasis	0.000369	0.00343	CbGbCtD
Dexamethasone—Alclometasone—Hydrocortisone—psoriasis	0.000369	0.0029	CrCrCtD
Dexamethasone—Beclomethasone—Betamethasone—psoriasis	0.000363	0.00285	CrCrCtD
Dexamethasone—Testolactone—Betamethasone—psoriasis	0.000363	0.00285	CrCrCtD
Dexamethasone—Prednicarbate—Betamethasone—psoriasis	0.000363	0.00285	CrCrCtD
Dexamethasone—Fluocinonide—Betamethasone—psoriasis	0.000363	0.00285	CrCrCtD
Dexamethasone—Clocortolone—Betamethasone—psoriasis	0.000363	0.00285	CrCrCtD
Dexamethasone—Budesonide—Hydrocortisone—psoriasis	0.000359	0.00282	CrCrCtD
Dexamethasone—Fluoxymesterone—Hydrocortisone—psoriasis	0.000359	0.00282	CrCrCtD
Dexamethasone—Testolactone—Triamcinolone—psoriasis	0.000354	0.00278	CrCrCtD
Dexamethasone—Clocortolone—Triamcinolone—psoriasis	0.000354	0.00278	CrCrCtD
Dexamethasone—Beclomethasone—Triamcinolone—psoriasis	0.000354	0.00278	CrCrCtD
Dexamethasone—Prednicarbate—Triamcinolone—psoriasis	0.000354	0.00278	CrCrCtD
Dexamethasone—Fluocinonide—Triamcinolone—psoriasis	0.000354	0.00278	CrCrCtD
Dexamethasone—Fluocortolone—Betamethasone—psoriasis	0.000352	0.00277	CrCrCtD
Dexamethasone—Flunisolide—Hydrocortisone—psoriasis	0.00035	0.00275	CrCrCtD
Dexamethasone—Desonide—Hydrocortisone—psoriasis	0.00035	0.00275	CrCrCtD
Dexamethasone—Prednisone—Hydrocortisone—psoriasis	0.00035	0.00275	CrCrCtD
Dexamethasone—Fludrocortisone—Hydrocortisone—psoriasis	0.00035	0.00275	CrCrCtD
Dexamethasone—Fluocortolone—Triamcinolone—psoriasis	0.000344	0.0027	CrCrCtD
Dexamethasone—Fluocinolone Acetonide—Betamethasone—psoriasis	0.000342	0.00269	CrCrCtD
Dexamethasone—Alclometasone—Betamethasone—psoriasis	0.000342	0.00269	CrCrCtD
Dexamethasone—Paramethasone—Hydrocortisone—psoriasis	0.000341	0.00268	CrCrCtD
Dexamethasone—ABCB1—Betamethasone—psoriasis	0.000337	0.00313	CbGbCtD
Dexamethasone—Testolactone—Prednisone—psoriasis	0.000336	0.00264	CrCrCtD
Dexamethasone—Prednicarbate—Prednisone—psoriasis	0.000336	0.00264	CrCrCtD
Dexamethasone—Alclometasone—Triamcinolone—psoriasis	0.000335	0.00263	CrCrCtD
Dexamethasone—Fluocinolone Acetonide—Triamcinolone—psoriasis	0.000335	0.00263	CrCrCtD
Dexamethasone—Fluoxymesterone—Betamethasone—psoriasis	0.000333	0.00262	CrCrCtD
Dexamethasone—Amcinonide—Betamethasone—psoriasis	0.000333	0.00262	CrCrCtD
Dexamethasone—Budesonide—Betamethasone—psoriasis	0.000333	0.00262	CrCrCtD
Dexamethasone—ABCB1—Prednisolone—psoriasis	0.000333	0.00309	CbGbCtD
Dexamethasone—Desoximetasone—Hydrocortisone—psoriasis	0.000332	0.00261	CrCrCtD
Dexamethasone—Clocortolone—Prednisolone—psoriasis	0.000328	0.00258	CrCrCtD
Dexamethasone—Beclomethasone—Prednisolone—psoriasis	0.000328	0.00258	CrCrCtD
Dexamethasone—Testolactone—Prednisolone—psoriasis	0.000328	0.00258	CrCrCtD
Dexamethasone—Prednicarbate—Prednisolone—psoriasis	0.000328	0.00258	CrCrCtD
Dexamethasone—Fluocortolone—Prednisone—psoriasis	0.000327	0.00257	CrCrCtD
Dexamethasone—Budesonide—Triamcinolone—psoriasis	0.000326	0.00256	CrCrCtD
Dexamethasone—Fluoxymesterone—Triamcinolone—psoriasis	0.000326	0.00256	CrCrCtD
Dexamethasone—Amcinonide—Triamcinolone—psoriasis	0.000326	0.00256	CrCrCtD
Dexamethasone—Fluorometholone—Hydrocortisone—psoriasis	0.000325	0.00255	CrCrCtD
Dexamethasone—Triamcinolone—Hydrocortisone—psoriasis	0.000325	0.00255	CrCrCtD
Dexamethasone—Fluprednidene Acetate—Hydrocortisone—psoriasis	0.000325	0.00255	CrCrCtD
Dexamethasone—Loteprednol—Hydrocortisone—psoriasis	0.000325	0.00255	CrCrCtD
Dexamethasone—Mometasone—Hydrocortisone—psoriasis	0.000325	0.00255	CrCrCtD
Dexamethasone—Diflorasone—Betamethasone—psoriasis	0.000325	0.00255	CrCrCtD
Dexamethasone—Fludrocortisone—Betamethasone—psoriasis	0.000325	0.00255	CrCrCtD
Dexamethasone—Flunisolide—Betamethasone—psoriasis	0.000325	0.00255	CrCrCtD
Dexamethasone—Clobetasol propionate—Betamethasone—psoriasis	0.000325	0.00255	CrCrCtD
Dexamethasone—Desonide—Betamethasone—psoriasis	0.000325	0.00255	CrCrCtD
Dexamethasone—Prednisone—Betamethasone—psoriasis	0.000325	0.00255	CrCrCtD
Dexamethasone—Fluocortolone—Prednisolone—psoriasis	0.000319	0.0025	CrCrCtD
Dexamethasone—Alclometasone—Prednisone—psoriasis	0.000317	0.00249	CrCrCtD
Dexamethasone—Rimexolone—Hydrocortisone—psoriasis	0.000317	0.00249	CrCrCtD
Dexamethasone—Betamethasone—Hydrocortisone—psoriasis	0.000317	0.00249	CrCrCtD
Dexamethasone—Desonide—Triamcinolone—psoriasis	0.000317	0.00249	CrCrCtD
Dexamethasone—Prednisone—Triamcinolone—psoriasis	0.000317	0.00249	CrCrCtD
Dexamethasone—Clobetasol propionate—Triamcinolone—psoriasis	0.000317	0.00249	CrCrCtD
Dexamethasone—Fludrocortisone—Triamcinolone—psoriasis	0.000317	0.00249	CrCrCtD
Dexamethasone—Flunisolide—Triamcinolone—psoriasis	0.000317	0.00249	CrCrCtD
Dexamethasone—Diflorasone—Triamcinolone—psoriasis	0.000317	0.00249	CrCrCtD
Dexamethasone—Paramethasone—Betamethasone—psoriasis	0.000316	0.00249	CrCrCtD
Dexamethasone—ABCB1—Hydrocortisone—psoriasis	0.000316	0.00293	CbGbCtD
Dexamethasone—ABCB1—Prednisone—psoriasis	0.000314	0.00292	CbGbCtD
Dexamethasone—Alclometasone—Prednisolone—psoriasis	0.00031	0.00243	CrCrCtD
Dexamethasone—Fluocinolone Acetonide—Prednisolone—psoriasis	0.00031	0.00243	CrCrCtD
Dexamethasone—Paramethasone—Triamcinolone—psoriasis	0.000309	0.00243	CrCrCtD
Dexamethasone—Budesonide—Prednisone—psoriasis	0.000309	0.00243	CrCrCtD
Dexamethasone—Amcinonide—Prednisone—psoriasis	0.000309	0.00243	CrCrCtD
Dexamethasone—Desoximetasone—Betamethasone—psoriasis	0.000309	0.00243	CrCrCtD
Dexamethasone—CYP2C9—Cyclosporine—psoriasis	0.000307	0.00285	CbGbCtD
Dexamethasone—Methylprednisolone—Hydrocortisone—psoriasis	0.000303	0.00238	CrCrCtD
Dexamethasone—Desoximetasone—Triamcinolone—psoriasis	0.000302	0.00237	CrCrCtD
Dexamethasone—Budesonide—Prednisolone—psoriasis	0.000302	0.00237	CrCrCtD
Dexamethasone—Amcinonide—Prednisolone—psoriasis	0.000302	0.00237	CrCrCtD
Dexamethasone—Fluoxymesterone—Prednisolone—psoriasis	0.000302	0.00237	CrCrCtD
Dexamethasone—Loteprednol—Betamethasone—psoriasis	0.000301	0.00237	CrCrCtD
Dexamethasone—Triamcinolone—Betamethasone—psoriasis	0.000301	0.00237	CrCrCtD
Dexamethasone—Fluprednidene Acetate—Betamethasone—psoriasis	0.000301	0.00237	CrCrCtD
Dexamethasone—Mometasone—Betamethasone—psoriasis	0.000301	0.00237	CrCrCtD
Dexamethasone—Fluorometholone—Betamethasone—psoriasis	0.000301	0.00237	CrCrCtD
Dexamethasone—Diflorasone—Prednisone—psoriasis	0.000301	0.00236	CrCrCtD
Dexamethasone—Flunisolide—Prednisone—psoriasis	0.000301	0.00236	CrCrCtD
Dexamethasone—Fludrocortisone—Prednisone—psoriasis	0.000301	0.00236	CrCrCtD
Dexamethasone—Clobetasol propionate—Prednisone—psoriasis	0.000301	0.00236	CrCrCtD
Dexamethasone—Desonide—Prednisone—psoriasis	0.000301	0.00236	CrCrCtD
Dexamethasone—ABCB1—Cyclosporine—psoriasis	0.000298	0.00277	CbGbCtD
Dexamethasone—Prednisolone—Hydrocortisone—psoriasis	0.000297	0.00233	CrCrCtD
Dexamethasone—Rimexolone—Betamethasone—psoriasis	0.000295	0.00231	CrCrCtD
Dexamethasone—Mometasone—Triamcinolone—psoriasis	0.000295	0.00231	CrCrCtD
Dexamethasone—Fluprednidene Acetate—Triamcinolone—psoriasis	0.000295	0.00231	CrCrCtD
Dexamethasone—Loteprednol—Triamcinolone—psoriasis	0.000295	0.00231	CrCrCtD
Dexamethasone—Fluorometholone—Triamcinolone—psoriasis	0.000295	0.00231	CrCrCtD
Dexamethasone—Clobetasol propionate—Prednisolone—psoriasis	0.000294	0.00231	CrCrCtD
Dexamethasone—Fludrocortisone—Prednisolone—psoriasis	0.000294	0.00231	CrCrCtD
Dexamethasone—Flunisolide—Prednisolone—psoriasis	0.000294	0.00231	CrCrCtD
Dexamethasone—Diflorasone—Prednisolone—psoriasis	0.000294	0.00231	CrCrCtD
Dexamethasone—Prednisone—Prednisolone—psoriasis	0.000294	0.00231	CrCrCtD
Dexamethasone—Desonide—Prednisolone—psoriasis	0.000294	0.00231	CrCrCtD
Dexamethasone—Paramethasone—Prednisone—psoriasis	0.000293	0.00231	CrCrCtD
Dexamethasone—Betamethasone—Triamcinolone—psoriasis	0.000288	0.00226	CrCrCtD
Dexamethasone—Rimexolone—Triamcinolone—psoriasis	0.000288	0.00226	CrCrCtD
Dexamethasone—Paramethasone—Prednisolone—psoriasis	0.000286	0.00225	CrCrCtD
Dexamethasone—Desoximetasone—Prednisone—psoriasis	0.000286	0.00225	CrCrCtD
Dexamethasone—Methylprednisolone—Betamethasone—psoriasis	0.000282	0.00221	CrCrCtD
Dexamethasone—CYP2D6—Cyclosporine—psoriasis	0.000281	0.00261	CbGbCtD
Dexamethasone—Fluprednidene Acetate—Prednisone—psoriasis	0.00028	0.0022	CrCrCtD
Dexamethasone—Loteprednol—Prednisone—psoriasis	0.00028	0.0022	CrCrCtD
Dexamethasone—Fluorometholone—Prednisone—psoriasis	0.00028	0.0022	CrCrCtD
Dexamethasone—Triamcinolone—Prednisone—psoriasis	0.00028	0.0022	CrCrCtD
Dexamethasone—Mometasone—Prednisone—psoriasis	0.00028	0.0022	CrCrCtD
Dexamethasone—Desoximetasone—Prednisolone—psoriasis	0.000279	0.0022	CrCrCtD
Dexamethasone—Prednisolone—Betamethasone—psoriasis	0.000276	0.00217	CrCrCtD
Dexamethasone—Methylprednisolone—Triamcinolone—psoriasis	0.000275	0.00216	CrCrCtD
Dexamethasone—Betamethasone—Prednisone—psoriasis	0.000273	0.00215	CrCrCtD
Dexamethasone—Rimexolone—Prednisone—psoriasis	0.000273	0.00215	CrCrCtD
Dexamethasone—Triamcinolone—Prednisolone—psoriasis	0.000273	0.00214	CrCrCtD
Dexamethasone—Mometasone—Prednisolone—psoriasis	0.000273	0.00214	CrCrCtD
Dexamethasone—Fluprednidene Acetate—Prednisolone—psoriasis	0.000273	0.00214	CrCrCtD
Dexamethasone—Loteprednol—Prednisolone—psoriasis	0.000273	0.00214	CrCrCtD
Dexamethasone—Fluorometholone—Prednisolone—psoriasis	0.000273	0.00214	CrCrCtD
Dexamethasone—CYP3A4—Cholecalciferol—psoriasis	0.000272	0.00252	CbGbCtD
Dexamethasone—Prednisolone—Triamcinolone—psoriasis	0.000269	0.00212	CrCrCtD
Dexamethasone—Betamethasone—Prednisolone—psoriasis	0.000267	0.00209	CrCrCtD
Dexamethasone—Rimexolone—Prednisolone—psoriasis	0.000267	0.00209	CrCrCtD
Dexamethasone—Hydrocortisone—Betamethasone—psoriasis	0.000265	0.00208	CrCrCtD
Dexamethasone—Methylprednisolone—Prednisone—psoriasis	0.000261	0.00205	CrCrCtD
Dexamethasone—Hydrocortisone—Triamcinolone—psoriasis	0.000259	0.00203	CrCrCtD
Dexamethasone—Prednisolone—Prednisone—psoriasis	0.000256	0.00201	CrCrCtD
Dexamethasone—Methylprednisolone—Prednisolone—psoriasis	0.000255	0.002	CrCrCtD
Dexamethasone—Hydrocortisone—Prednisone—psoriasis	0.000245	0.00193	CrCrCtD
Dexamethasone—Hydrocortisone—Prednisolone—psoriasis	0.00024	0.00188	CrCrCtD
Dexamethasone—CYP3A4—Mycophenolate mofetil—psoriasis	0.000236	0.00219	CbGbCtD
Dexamethasone—CYP3A4—Triamcinolone—psoriasis	0.000236	0.00219	CbGbCtD
Dexamethasone—CYP3A4—Betamethasone—psoriasis	0.000202	0.00188	CbGbCtD
Dexamethasone—CYP3A4—Prednisolone—psoriasis	0.000199	0.00185	CbGbCtD
Dexamethasone—CYP3A4—Hydrocortisone—psoriasis	0.000189	0.00176	CbGbCtD
Dexamethasone—CYP3A4—Prednisone—psoriasis	0.000188	0.00175	CbGbCtD
Dexamethasone—CYP3A4—Cyclosporine—psoriasis	0.000179	0.00166	CbGbCtD
Dexamethasone—ABCB1—Methotrexate—psoriasis	0.000158	0.00147	CbGbCtD
Dexamethasone—PTGS2—Fluocinonide—Clobetasol propionate—psoriasis	6.86e-05	0.173	CbGdCrCtD
Dexamethasone—PTGS2—Fluocinonide—Beclomethasone—psoriasis	5.49e-05	0.139	CbGdCrCtD
Dexamethasone—PTGS2—Fluocinonide—Fluocinolone Acetonide—psoriasis	5.34e-05	0.135	CbGdCrCtD
Dexamethasone—PTGS2—Fluticasone Propionate—Clobetasol propionate—psoriasis	4.14e-05	0.104	CbGdCrCtD
Dexamethasone—PTGS2—Fluticasone Propionate—Beclomethasone—psoriasis	3.32e-05	0.0836	CbGdCrCtD
Dexamethasone—PTGS2—Fluticasone Propionate—Fluocinonide—psoriasis	3.32e-05	0.0836	CbGdCrCtD
Dexamethasone—PTGS2—Fluticasone Propionate—Fluocinolone Acetonide—psoriasis	3.22e-05	0.0813	CbGdCrCtD
Dexamethasone—PTGS2—Fluocinonide—Betamethasone—psoriasis	2.5e-05	0.0632	CbGdCrCtD
Dexamethasone—PTGS2—Fluocinonide—Triamcinolone—psoriasis	2.45e-05	0.0617	CbGdCrCtD
Dexamethasone—PTGS2—Fluticasone Propionate—Betamethasone—psoriasis	1.51e-05	0.0381	CbGdCrCtD
Dexamethasone—PTGS2—Fluticasone Propionate—Triamcinolone—psoriasis	1.48e-05	0.0373	CbGdCrCtD
Dexamethasone—NOS2—Circadian rythm related genes—IL6—psoriasis	3.9e-06	0.000294	CbGpPWpGaD
Dexamethasone—NR3C2—Gene Expression—VDR—psoriasis	3.88e-06	0.000292	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—NDUFA5—psoriasis	3.86e-06	0.000291	CbGpPWpGaD
Dexamethasone—CYP19A1—Integrated Breast Cancer Pathway—JUN—psoriasis	3.86e-06	0.000291	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	3.84e-06	0.000289	CbGpPWpGaD
Dexamethasone—PTGS2—Selenium Micronutrient Network—NFKB1—psoriasis	3.82e-06	0.000288	CbGpPWpGaD
Dexamethasone—NR3C1—AP-1 transcription factor network—IL6—psoriasis	3.8e-06	0.000286	CbGpPWpGaD
Dexamethasone—ABCG2—Transmembrane transport of small molecules—CARM1—psoriasis	3.77e-06	0.000284	CbGpPWpGaD
Dexamethasone—CYP19A1—Integrated Breast Cancer Pathway—NFKB1—psoriasis	3.72e-06	0.00028	CbGpPWpGaD
Dexamethasone—NR3C1—Glucocorticoid receptor regulatory network—TP53—psoriasis	3.66e-06	0.000276	CbGpPWpGaD
Dexamethasone—PTGS2—Spinal Cord Injury—IFNG—psoriasis	3.63e-06	0.000274	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—CYP2S1—psoriasis	3.61e-06	0.000272	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—CYP2S1—psoriasis	3.58e-06	0.00027	CbGpPWpGaD
Dexamethasone—Musculoskeletal discomfort—Mycophenolate mofetil—psoriasis	3.58e-06	8.79e-05	CcSEcCtD
Dexamethasone—Anaphylactic shock—Hydrocortisone—psoriasis	3.58e-06	8.79e-05	CcSEcCtD
Dexamethasone—Oedema—Hydrocortisone—psoriasis	3.58e-06	8.79e-05	CcSEcCtD
Dexamethasone—Convulsion—Triamcinolone—psoriasis	3.58e-06	8.79e-05	CcSEcCtD
Dexamethasone—Tachycardia—Prednisolone—psoriasis	3.58e-06	8.78e-05	CcSEcCtD
Dexamethasone—Asthenia—Mycophenolic acid—psoriasis	3.57e-06	8.77e-05	CcSEcCtD
Dexamethasone—CYP17A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	3.57e-06	0.000269	CbGpPWpGaD
Dexamethasone—NR3C1—SIDS Susceptibility Pathways—CXCL8—psoriasis	3.57e-06	0.000269	CbGpPWpGaD
Dexamethasone—Hypertension—Triamcinolone—psoriasis	3.57e-06	8.76e-05	CcSEcCtD
Dexamethasone—Infection—Hydrocortisone—psoriasis	3.56e-06	8.73e-05	CcSEcCtD
Dexamethasone—Insomnia—Mycophenolate mofetil—psoriasis	3.55e-06	8.73e-05	CcSEcCtD
Dexamethasone—ABCB1—Allograft Rejection—IFNG—psoriasis	3.55e-06	0.000267	CbGpPWpGaD
Dexamethasone—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	3.55e-06	0.000267	CbGpPWpGaD
Dexamethasone—Dyspepsia—Cyclosporine—psoriasis	3.55e-06	8.71e-05	CcSEcCtD
Dexamethasone—Hyperhidrosis—Prednisolone—psoriasis	3.54e-06	8.7e-05	CcSEcCtD
Dexamethasone—PGR—Signaling by ERBB4—IL6—psoriasis	3.54e-06	0.000266	CbGpPWpGaD
Dexamethasone—NR0B1—Gene Expression—PPARG—psoriasis	3.54e-06	0.000266	CbGpPWpGaD
Dexamethasone—Nausea—Hydroxyurea—psoriasis	3.53e-06	8.67e-05	CcSEcCtD
Dexamethasone—Paraesthesia—Mycophenolate mofetil—psoriasis	3.53e-06	8.66e-05	CcSEcCtD
Dexamethasone—Pruritus—Mycophenolic acid—psoriasis	3.52e-06	8.65e-05	CcSEcCtD
Dexamethasone—Shock—Hydrocortisone—psoriasis	3.52e-06	8.65e-05	CcSEcCtD
Dexamethasone—Myalgia—Triamcinolone—psoriasis	3.52e-06	8.63e-05	CcSEcCtD
Dexamethasone—Nervous system disorder—Hydrocortisone—psoriasis	3.51e-06	8.62e-05	CcSEcCtD
Dexamethasone—Eye disorder—Prednisone—psoriasis	3.5e-06	8.6e-05	CcSEcCtD
Dexamethasone—Decreased appetite—Cyclosporine—psoriasis	3.5e-06	8.6e-05	CcSEcCtD
Dexamethasone—Tachycardia—Hydrocortisone—psoriasis	3.49e-06	8.58e-05	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Cyclosporine—psoriasis	3.48e-06	8.54e-05	CcSEcCtD
Dexamethasone—Ill-defined disorder—Betamethasone—psoriasis	3.48e-06	8.54e-05	CcSEcCtD
Dexamethasone—Discomfort—Triamcinolone—psoriasis	3.47e-06	8.53e-05	CcSEcCtD
Dexamethasone—Fatigue—Cyclosporine—psoriasis	3.47e-06	8.53e-05	CcSEcCtD
Dexamethasone—Hyperhidrosis—Hydrocortisone—psoriasis	3.46e-06	8.5e-05	CcSEcCtD
Dexamethasone—Dyspepsia—Mycophenolate mofetil—psoriasis	3.46e-06	8.49e-05	CcSEcCtD
Dexamethasone—Pain—Cyclosporine—psoriasis	3.44e-06	8.46e-05	CcSEcCtD
Dexamethasone—Angioedema—Betamethasone—psoriasis	3.42e-06	8.41e-05	CcSEcCtD
Dexamethasone—PGR—Generic Transcription Pathway—PPARG—psoriasis	3.42e-06	0.000257	CbGpPWpGaD
Dexamethasone—Decreased appetite—Mycophenolate mofetil—psoriasis	3.42e-06	8.39e-05	CcSEcCtD
Dexamethasone—Anorexia—Hydrocortisone—psoriasis	3.41e-06	8.38e-05	CcSEcCtD
Dexamethasone—Diarrhoea—Mycophenolic acid—psoriasis	3.41e-06	8.37e-05	CcSEcCtD
Dexamethasone—Angiopathy—Prednisone—psoriasis	3.4e-06	8.35e-05	CcSEcCtD
Dexamethasone—PLA2G1B—Metabolism—CAT—psoriasis	3.39e-06	0.000255	CbGpPWpGaD
Dexamethasone—Conjunctivitis—Methotrexate—psoriasis	3.39e-06	8.33e-05	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	3.39e-06	8.33e-05	CcSEcCtD
Dexamethasone—PTGS2—Spinal Cord Injury—CXCL8—psoriasis	3.38e-06	0.000254	CbGpPWpGaD
Dexamethasone—Malaise—Betamethasone—psoriasis	3.38e-06	8.3e-05	CcSEcCtD
Dexamethasone—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—psoriasis	3.37e-06	0.000254	CbGpPWpGaD
Dexamethasone—Anaphylactic shock—Triamcinolone—psoriasis	3.37e-06	8.28e-05	CcSEcCtD
Dexamethasone—Oedema—Triamcinolone—psoriasis	3.37e-06	8.28e-05	CcSEcCtD
Dexamethasone—Vertigo—Betamethasone—psoriasis	3.37e-06	8.27e-05	CcSEcCtD
Dexamethasone—Syncope—Betamethasone—psoriasis	3.36e-06	8.25e-05	CcSEcCtD
Dexamethasone—Pain—Mycophenolate mofetil—psoriasis	3.36e-06	8.25e-05	CcSEcCtD
Dexamethasone—NR3C1—Glucocorticoid receptor regulatory network—IL6—psoriasis	3.35e-06	0.000252	CbGpPWpGaD
Dexamethasone—Arrhythmia—Prednisone—psoriasis	3.35e-06	8.22e-05	CcSEcCtD
Dexamethasone—Infection—Triamcinolone—psoriasis	3.35e-06	8.22e-05	CcSEcCtD
Dexamethasone—Hypotension—Hydrocortisone—psoriasis	3.34e-06	8.21e-05	CcSEcCtD
Dexamethasone—CYP17A1—Metabolism—CARM1—psoriasis	3.33e-06	0.00025	CbGpPWpGaD
Dexamethasone—NR3C1—Adipogenesis—STAT3—psoriasis	3.32e-06	0.00025	CbGpPWpGaD
Dexamethasone—Feeling abnormal—Cyclosporine—psoriasis	3.32e-06	8.15e-05	CcSEcCtD
Dexamethasone—NR3C1—SIDS Susceptibility Pathways—JUN—psoriasis	3.32e-06	0.00025	CbGpPWpGaD
Dexamethasone—Shock—Triamcinolone—psoriasis	3.32e-06	8.14e-05	CcSEcCtD
Dexamethasone—Insomnia—Prednisolone—psoriasis	3.31e-06	8.14e-05	CcSEcCtD
Dexamethasone—Alopecia—Prednisone—psoriasis	3.31e-06	8.14e-05	CcSEcCtD
Dexamethasone—ABCB1—Allograft Rejection—CXCL8—psoriasis	3.3e-06	0.000249	CbGpPWpGaD
Dexamethasone—Gastrointestinal pain—Cyclosporine—psoriasis	3.29e-06	8.09e-05	CcSEcCtD
Dexamethasone—Loss of consciousness—Betamethasone—psoriasis	3.29e-06	8.09e-05	CcSEcCtD
Dexamethasone—Dizziness—Mycophenolic acid—psoriasis	3.29e-06	8.09e-05	CcSEcCtD
Dexamethasone—Paraesthesia—Prednisolone—psoriasis	3.29e-06	8.08e-05	CcSEcCtD
Dexamethasone—Tachycardia—Triamcinolone—psoriasis	3.29e-06	8.08e-05	CcSEcCtD
Dexamethasone—CYP2A6—Metabolism—CYP2S1—psoriasis	3.28e-06	0.000247	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	3.26e-06	0.000246	CbGpPWpGaD
Dexamethasone—Erythema—Prednisone—psoriasis	3.26e-06	8.01e-05	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Hydrocortisone—psoriasis	3.26e-06	8.01e-05	CcSEcCtD
Dexamethasone—Hyperhidrosis—Triamcinolone—psoriasis	3.26e-06	8e-05	CcSEcCtD
Dexamethasone—Convulsion—Betamethasone—psoriasis	3.25e-06	7.97e-05	CcSEcCtD
Dexamethasone—PTGS2—Metabolism—NDUFA5—psoriasis	3.24e-06	0.000244	CbGpPWpGaD
Dexamethasone—Feeling abnormal—Mycophenolate mofetil—psoriasis	3.24e-06	7.95e-05	CcSEcCtD
Dexamethasone—Insomnia—Hydrocortisone—psoriasis	3.24e-06	7.95e-05	CcSEcCtD
Dexamethasone—Hypertension—Betamethasone—psoriasis	3.24e-06	7.95e-05	CcSEcCtD
Dexamethasone—CYP4A11—Metabolism of lipids and lipoproteins—APOE—psoriasis	3.23e-06	0.000243	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	3.22e-06	0.000243	CbGpPWpGaD
Dexamethasone—Paraesthesia—Hydrocortisone—psoriasis	3.21e-06	7.89e-05	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	3.21e-06	7.89e-05	CcSEcCtD
Dexamethasone—Urticaria—Cyclosporine—psoriasis	3.2e-06	7.86e-05	CcSEcCtD
Dexamethasone—NR3C1—SIDS Susceptibility Pathways—NFKB1—psoriasis	3.19e-06	0.00024	CbGpPWpGaD
Dexamethasone—Myalgia—Betamethasone—psoriasis	3.19e-06	7.83e-05	CcSEcCtD
Dexamethasone—Body temperature increased—Cyclosporine—psoriasis	3.18e-06	7.82e-05	CcSEcCtD
Dexamethasone—Abdominal pain—Cyclosporine—psoriasis	3.18e-06	7.82e-05	CcSEcCtD
Dexamethasone—Anxiety—Betamethasone—psoriasis	3.18e-06	7.81e-05	CcSEcCtD
Dexamethasone—Vomiting—Mycophenolic acid—psoriasis	3.17e-06	7.77e-05	CcSEcCtD
Dexamethasone—Discomfort—Betamethasone—psoriasis	3.15e-06	7.74e-05	CcSEcCtD
Dexamethasone—Dyspepsia—Hydrocortisone—psoriasis	3.15e-06	7.74e-05	CcSEcCtD
Dexamethasone—Haemoglobin—Methotrexate—psoriasis	3.15e-06	7.73e-05	CcSEcCtD
Dexamethasone—Rash—Mycophenolic acid—psoriasis	3.14e-06	7.71e-05	CcSEcCtD
Dexamethasone—Dermatitis—Mycophenolic acid—psoriasis	3.14e-06	7.7e-05	CcSEcCtD
Dexamethasone—Pain—Prednisolone—psoriasis	3.13e-06	7.7e-05	CcSEcCtD
Dexamethasone—Haemorrhage—Methotrexate—psoriasis	3.13e-06	7.69e-05	CcSEcCtD
Dexamethasone—Urticaria—Mycophenolate mofetil—psoriasis	3.12e-06	7.67e-05	CcSEcCtD
Dexamethasone—Headache—Mycophenolic acid—psoriasis	3.12e-06	7.66e-05	CcSEcCtD
Dexamethasone—CYP2B6—Metabolism—NDUFA5—psoriasis	3.12e-06	0.000235	CbGpPWpGaD
Dexamethasone—Decreased appetite—Hydrocortisone—psoriasis	3.11e-06	7.64e-05	CcSEcCtD
Dexamethasone—CYP17A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	3.11e-06	0.000234	CbGpPWpGaD
Dexamethasone—Body temperature increased—Mycophenolate mofetil—psoriasis	3.11e-06	7.63e-05	CcSEcCtD
Dexamethasone—Abdominal pain—Mycophenolate mofetil—psoriasis	3.11e-06	7.63e-05	CcSEcCtD
Dexamethasone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	3.1e-06	0.000233	CbGpPWpGaD
Dexamethasone—Gastrointestinal disorder—Hydrocortisone—psoriasis	3.09e-06	7.59e-05	CcSEcCtD
Dexamethasone—Fatigue—Hydrocortisone—psoriasis	3.09e-06	7.58e-05	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Triamcinolone—psoriasis	3.07e-06	7.54e-05	CcSEcCtD
Dexamethasone—Pain—Hydrocortisone—psoriasis	3.06e-06	7.52e-05	CcSEcCtD
Dexamethasone—Anaphylactic shock—Betamethasone—psoriasis	3.06e-06	7.51e-05	CcSEcCtD
Dexamethasone—Oedema—Betamethasone—psoriasis	3.06e-06	7.51e-05	CcSEcCtD
Dexamethasone—CYP2E1—Metabolism—NDUFA5—psoriasis	3.05e-06	0.00023	CbGpPWpGaD
Dexamethasone—Insomnia—Triamcinolone—psoriasis	3.05e-06	7.49e-05	CcSEcCtD
Dexamethasone—CYP3A5—Metabolism—NDUFA5—psoriasis	3.05e-06	0.000229	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—SOCS1—psoriasis	3.04e-06	0.000229	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—CARM1—psoriasis	3.04e-06	0.000229	CbGpPWpGaD
Dexamethasone—Infection—Betamethasone—psoriasis	3.04e-06	7.46e-05	CcSEcCtD
Dexamethasone—Ill-defined disorder—Prednisone—psoriasis	3.03e-06	7.44e-05	CcSEcCtD
Dexamethasone—Paraesthesia—Triamcinolone—psoriasis	3.03e-06	7.43e-05	CcSEcCtD
Dexamethasone—PTGS2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	3.02e-06	0.000228	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—CCL20—psoriasis	3.02e-06	0.000228	CbGpPWpGaD
Dexamethasone—Feeling abnormal—Prednisolone—psoriasis	3.02e-06	7.42e-05	CcSEcCtD
Dexamethasone—Visual impairment—Methotrexate—psoriasis	3.02e-06	7.41e-05	CcSEcCtD
Dexamethasone—CYP4A11—Metabolism—CARM1—psoriasis	3.01e-06	0.000227	CbGpPWpGaD
Dexamethasone—Shock—Betamethasone—psoriasis	3.01e-06	7.39e-05	CcSEcCtD
Dexamethasone—Nervous system disorder—Betamethasone—psoriasis	3e-06	7.37e-05	CcSEcCtD
Dexamethasone—Thrombocytopenia—Betamethasone—psoriasis	2.99e-06	7.35e-05	CcSEcCtD
Dexamethasone—Tachycardia—Betamethasone—psoriasis	2.98e-06	7.33e-05	CcSEcCtD
Dexamethasone—Angioedema—Prednisone—psoriasis	2.98e-06	7.32e-05	CcSEcCtD
Dexamethasone—PTGS2—Selenium Micronutrient Network—TNF—psoriasis	2.97e-06	0.000224	CbGpPWpGaD
Dexamethasone—Dyspepsia—Triamcinolone—psoriasis	2.97e-06	7.29e-05	CcSEcCtD
Dexamethasone—Nausea—Mycophenolic acid—psoriasis	2.96e-06	7.26e-05	CcSEcCtD
Dexamethasone—Hyperhidrosis—Betamethasone—psoriasis	2.96e-06	7.26e-05	CcSEcCtD
Dexamethasone—Feeling abnormal—Hydrocortisone—psoriasis	2.95e-06	7.24e-05	CcSEcCtD
Dexamethasone—Malaise—Prednisone—psoriasis	2.94e-06	7.23e-05	CcSEcCtD
Dexamethasone—Vertigo—Prednisone—psoriasis	2.93e-06	7.2e-05	CcSEcCtD
Dexamethasone—Eye disorder—Methotrexate—psoriasis	2.93e-06	7.19e-05	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Hydrocortisone—psoriasis	2.93e-06	7.19e-05	CcSEcCtD
Dexamethasone—Syncope—Prednisone—psoriasis	2.93e-06	7.19e-05	CcSEcCtD
Dexamethasone—Anorexia—Betamethasone—psoriasis	2.92e-06	7.16e-05	CcSEcCtD
Dexamethasone—Urticaria—Prednisolone—psoriasis	2.91e-06	7.15e-05	CcSEcCtD
Dexamethasone—Fatigue—Triamcinolone—psoriasis	2.91e-06	7.14e-05	CcSEcCtD
Dexamethasone—ANXA1—Signaling by GPCR—TYK2—psoriasis	2.9e-06	0.000218	CbGpPWpGaD
Dexamethasone—NR3C1—SIDS Susceptibility Pathways—VEGFA—psoriasis	2.9e-06	0.000218	CbGpPWpGaD
Dexamethasone—Asthenia—Cyclosporine—psoriasis	2.89e-06	7.1e-05	CcSEcCtD
Dexamethasone—Pain—Triamcinolone—psoriasis	2.88e-06	7.08e-05	CcSEcCtD
Dexamethasone—CYP1A1—Metabolism—NDUFA5—psoriasis	2.88e-06	0.000217	CbGpPWpGaD
Dexamethasone—NR3C1—Adipogenesis—TNF—psoriasis	2.87e-06	0.000216	CbGpPWpGaD
Dexamethasone—Loss of consciousness—Prednisone—psoriasis	2.87e-06	7.04e-05	CcSEcCtD
Dexamethasone—ABCB11—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.87e-06	0.000216	CbGpPWpGaD
Dexamethasone—Hypotension—Betamethasone—psoriasis	2.86e-06	7.02e-05	CcSEcCtD
Dexamethasone—Pruritus—Cyclosporine—psoriasis	2.85e-06	7e-05	CcSEcCtD
Dexamethasone—Urticaria—Hydrocortisone—psoriasis	2.84e-06	6.98e-05	CcSEcCtD
Dexamethasone—CYP11A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.84e-06	0.000214	CbGpPWpGaD
Dexamethasone—Angiopathy—Methotrexate—psoriasis	2.84e-06	6.98e-05	CcSEcCtD
Dexamethasone—NR3C1—Generic Transcription Pathway—VDR—psoriasis	2.83e-06	0.000213	CbGpPWpGaD
Dexamethasone—Body temperature increased—Hydrocortisone—psoriasis	2.83e-06	6.95e-05	CcSEcCtD
Dexamethasone—Abdominal pain—Hydrocortisone—psoriasis	2.83e-06	6.95e-05	CcSEcCtD
Dexamethasone—Convulsion—Prednisone—psoriasis	2.83e-06	6.94e-05	CcSEcCtD
Dexamethasone—Asthenia—Mycophenolate mofetil—psoriasis	2.82e-06	6.92e-05	CcSEcCtD
Dexamethasone—Hypertension—Prednisone—psoriasis	2.82e-06	6.92e-05	CcSEcCtD
Dexamethasone—CYP4A11—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.81e-06	0.000212	CbGpPWpGaD
Dexamethasone—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—psoriasis	2.8e-06	0.000211	CbGpPWpGaD
Dexamethasone—Musculoskeletal discomfort—Betamethasone—psoriasis	2.79e-06	6.84e-05	CcSEcCtD
Dexamethasone—ANXA1—GPCR downstream signaling—CXCL8—psoriasis	2.78e-06	0.000209	CbGpPWpGaD
Dexamethasone—Pruritus—Mycophenolate mofetil—psoriasis	2.78e-06	6.83e-05	CcSEcCtD
Dexamethasone—Myalgia—Prednisone—psoriasis	2.78e-06	6.82e-05	CcSEcCtD
Dexamethasone—Feeling abnormal—Triamcinolone—psoriasis	2.78e-06	6.82e-05	CcSEcCtD
Dexamethasone—Anxiety—Prednisone—psoriasis	2.77e-06	6.8e-05	CcSEcCtD
Dexamethasone—Alopecia—Methotrexate—psoriasis	2.77e-06	6.8e-05	CcSEcCtD
Dexamethasone—Insomnia—Betamethasone—psoriasis	2.77e-06	6.79e-05	CcSEcCtD
Dexamethasone—PTGS2—Metabolism—CYP2S1—psoriasis	2.76e-06	0.000208	CbGpPWpGaD
Dexamethasone—Diarrhoea—Cyclosporine—psoriasis	2.76e-06	6.77e-05	CcSEcCtD
Dexamethasone—Paraesthesia—Betamethasone—psoriasis	2.75e-06	6.74e-05	CcSEcCtD
Dexamethasone—Discomfort—Prednisone—psoriasis	2.74e-06	6.74e-05	CcSEcCtD
Dexamethasone—Erythema—Methotrexate—psoriasis	2.73e-06	6.7e-05	CcSEcCtD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	2.72e-06	0.000205	CbGpPWpGaD
Dexamethasone—NR3C2—Gene Expression—PPARG—psoriasis	2.7e-06	0.000203	CbGpPWpGaD
Dexamethasone—NOS2—Hemostasis—VEGFA—psoriasis	2.7e-06	0.000203	CbGpPWpGaD
Dexamethasone—Dyspepsia—Betamethasone—psoriasis	2.69e-06	6.61e-05	CcSEcCtD
Dexamethasone—Diarrhoea—Mycophenolate mofetil—psoriasis	2.69e-06	6.6e-05	CcSEcCtD
Dexamethasone—CYP1A1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.68e-06	0.000202	CbGpPWpGaD
Dexamethasone—ABCB1—Allograft Rejection—VEGFA—psoriasis	2.68e-06	0.000202	CbGpPWpGaD
Dexamethasone—Urticaria—Triamcinolone—psoriasis	2.68e-06	6.58e-05	CcSEcCtD
Dexamethasone—CYP3A43—Metabolism—CAT—psoriasis	2.67e-06	0.000201	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—CARM1—psoriasis	2.67e-06	0.000201	CbGpPWpGaD
Dexamethasone—Body temperature increased—Triamcinolone—psoriasis	2.66e-06	6.54e-05	CcSEcCtD
Dexamethasone—Dizziness—Cyclosporine—psoriasis	2.66e-06	6.54e-05	CcSEcCtD
Dexamethasone—Oedema—Prednisone—psoriasis	2.66e-06	6.54e-05	CcSEcCtD
Dexamethasone—Anaphylactic shock—Prednisone—psoriasis	2.66e-06	6.54e-05	CcSEcCtD
Dexamethasone—Decreased appetite—Betamethasone—psoriasis	2.66e-06	6.53e-05	CcSEcCtD
Dexamethasone—CYP2B6—Metabolism—CYP2S1—psoriasis	2.65e-06	0.000199	CbGpPWpGaD
Dexamethasone—Infection—Prednisone—psoriasis	2.65e-06	6.5e-05	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Betamethasone—psoriasis	2.64e-06	6.48e-05	CcSEcCtD
Dexamethasone—CYP2C8—Metabolism—NDUFA5—psoriasis	2.64e-06	0.000199	CbGpPWpGaD
Dexamethasone—PLA2G1B—Metabolism—APOE—psoriasis	2.64e-06	0.000199	CbGpPWpGaD
Dexamethasone—Fatigue—Betamethasone—psoriasis	2.64e-06	6.48e-05	CcSEcCtD
Dexamethasone—Shock—Prednisone—psoriasis	2.62e-06	6.44e-05	CcSEcCtD
Dexamethasone—Pain—Betamethasone—psoriasis	2.62e-06	6.42e-05	CcSEcCtD
Dexamethasone—Nervous system disorder—Prednisone—psoriasis	2.61e-06	6.41e-05	CcSEcCtD
Dexamethasone—Tachycardia—Prednisone—psoriasis	2.6e-06	6.38e-05	CcSEcCtD
Dexamethasone—Dizziness—Mycophenolate mofetil—psoriasis	2.6e-06	6.38e-05	CcSEcCtD
Dexamethasone—CYP2E1—Metabolism—CYP2S1—psoriasis	2.6e-06	0.000195	CbGpPWpGaD
Dexamethasone—NOS2—Disease—HLA-A—psoriasis	2.59e-06	0.000195	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—CYP2S1—psoriasis	2.59e-06	0.000195	CbGpPWpGaD
Dexamethasone—Hyperhidrosis—Prednisone—psoriasis	2.57e-06	6.32e-05	CcSEcCtD
Dexamethasone—Asthenia—Hydrocortisone—psoriasis	2.57e-06	6.31e-05	CcSEcCtD
Dexamethasone—Vomiting—Cyclosporine—psoriasis	2.56e-06	6.29e-05	CcSEcCtD
Dexamethasone—CYP19A1—Integrated Breast Cancer Pathway—TP53—psoriasis	2.55e-06	0.000192	CbGpPWpGaD
Dexamethasone—Rash—Cyclosporine—psoriasis	2.54e-06	6.24e-05	CcSEcCtD
Dexamethasone—Anorexia—Prednisone—psoriasis	2.54e-06	6.23e-05	CcSEcCtD
Dexamethasone—Dermatitis—Cyclosporine—psoriasis	2.54e-06	6.23e-05	CcSEcCtD
Dexamethasone—Pruritus—Hydrocortisone—psoriasis	2.53e-06	6.22e-05	CcSEcCtD
Dexamethasone—Ill-defined disorder—Methotrexate—psoriasis	2.53e-06	6.21e-05	CcSEcCtD
Dexamethasone—ANXA1—Signaling by GPCR—CXCL8—psoriasis	2.53e-06	0.00019	CbGpPWpGaD
Dexamethasone—Headache—Cyclosporine—psoriasis	2.52e-06	6.2e-05	CcSEcCtD
Dexamethasone—Feeling abnormal—Betamethasone—psoriasis	2.52e-06	6.19e-05	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Betamethasone—psoriasis	2.5e-06	6.14e-05	CcSEcCtD
Dexamethasone—Vomiting—Mycophenolate mofetil—psoriasis	2.5e-06	6.14e-05	CcSEcCtD
Dexamethasone—ABCB11—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.5e-06	0.000188	CbGpPWpGaD
Dexamethasone—NR3C1—SIDS Susceptibility Pathways—TNF—psoriasis	2.48e-06	0.000187	CbGpPWpGaD
Dexamethasone—Rash—Mycophenolate mofetil—psoriasis	2.48e-06	6.08e-05	CcSEcCtD
Dexamethasone—Dermatitis—Mycophenolate mofetil—psoriasis	2.47e-06	6.08e-05	CcSEcCtD
Dexamethasone—Headache—Mycophenolate mofetil—psoriasis	2.46e-06	6.05e-05	CcSEcCtD
Dexamethasone—CYP2C8—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.46e-06	0.000185	CbGpPWpGaD
Dexamethasone—Malaise—Methotrexate—psoriasis	2.46e-06	6.04e-05	CcSEcCtD
Dexamethasone—Vertigo—Methotrexate—psoriasis	2.45e-06	6.02e-05	CcSEcCtD
Dexamethasone—Diarrhoea—Hydrocortisone—psoriasis	2.45e-06	6.01e-05	CcSEcCtD
Dexamethasone—CYP1A1—Metabolism—CYP2S1—psoriasis	2.45e-06	0.000184	CbGpPWpGaD
Dexamethasone—Urticaria—Betamethasone—psoriasis	2.43e-06	5.97e-05	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Prednisone—psoriasis	2.43e-06	5.96e-05	CcSEcCtD
Dexamethasone—Dizziness—Prednisolone—psoriasis	2.42e-06	5.95e-05	CcSEcCtD
Dexamethasone—NOS2—Disease—APOE—psoriasis	2.42e-06	0.000182	CbGpPWpGaD
Dexamethasone—Asthenia—Triamcinolone—psoriasis	2.42e-06	5.94e-05	CcSEcCtD
Dexamethasone—Abdominal pain—Betamethasone—psoriasis	2.42e-06	5.94e-05	CcSEcCtD
Dexamethasone—Body temperature increased—Betamethasone—psoriasis	2.42e-06	5.94e-05	CcSEcCtD
Dexamethasone—Insomnia—Prednisone—psoriasis	2.41e-06	5.92e-05	CcSEcCtD
Dexamethasone—PTGS2—Selenium Micronutrient Network—IL6—psoriasis	2.4e-06	0.000181	CbGpPWpGaD
Dexamethasone—Nausea—Cyclosporine—psoriasis	2.39e-06	5.88e-05	CcSEcCtD
Dexamethasone—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.39e-06	0.00018	CbGpPWpGaD
Dexamethasone—Paraesthesia—Prednisone—psoriasis	2.39e-06	5.87e-05	CcSEcCtD
Dexamethasone—Pruritus—Triamcinolone—psoriasis	2.38e-06	5.86e-05	CcSEcCtD
Dexamethasone—Dizziness—Hydrocortisone—psoriasis	2.37e-06	5.81e-05	CcSEcCtD
Dexamethasone—Convulsion—Methotrexate—psoriasis	2.36e-06	5.8e-05	CcSEcCtD
Dexamethasone—PGR—Gene Expression—VDR—psoriasis	2.36e-06	0.000178	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—NDUFA5—psoriasis	2.35e-06	0.000177	CbGpPWpGaD
Dexamethasone—PTGS2—Spinal Cord Injury—TNF—psoriasis	2.35e-06	0.000177	CbGpPWpGaD
Dexamethasone—Dyspepsia—Prednisone—psoriasis	2.34e-06	5.76e-05	CcSEcCtD
Dexamethasone—Nausea—Mycophenolate mofetil—psoriasis	2.33e-06	5.73e-05	CcSEcCtD
Dexamethasone—Myalgia—Methotrexate—psoriasis	2.32e-06	5.7e-05	CcSEcCtD
Dexamethasone—NR3C1—Adipogenesis—IL6—psoriasis	2.32e-06	0.000175	CbGpPWpGaD
Dexamethasone—Decreased appetite—Prednisone—psoriasis	2.32e-06	5.69e-05	CcSEcCtD
Dexamethasone—Rash—Prednisolone—psoriasis	2.31e-06	5.68e-05	CcSEcCtD
Dexamethasone—Dermatitis—Prednisolone—psoriasis	2.31e-06	5.67e-05	CcSEcCtD
Dexamethasone—ABCB1—Allograft Rejection—TNF—psoriasis	2.3e-06	0.000173	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—NDUFA5—psoriasis	2.3e-06	0.000173	CbGpPWpGaD
Dexamethasone—PLA2G1B—Metabolism—PPARG—psoriasis	2.3e-06	0.000173	CbGpPWpGaD
Dexamethasone—Fatigue—Prednisone—psoriasis	2.3e-06	5.64e-05	CcSEcCtD
Dexamethasone—Headache—Prednisolone—psoriasis	2.3e-06	5.64e-05	CcSEcCtD
Dexamethasone—Discomfort—Methotrexate—psoriasis	2.29e-06	5.63e-05	CcSEcCtD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	2.29e-06	0.000172	CbGpPWpGaD
Dexamethasone—NR3C1—Gene Expression—CARM1—psoriasis	2.28e-06	0.000172	CbGpPWpGaD
Dexamethasone—Vomiting—Hydrocortisone—psoriasis	2.28e-06	5.59e-05	CcSEcCtD
Dexamethasone—Rash—Hydrocortisone—psoriasis	2.26e-06	5.54e-05	CcSEcCtD
Dexamethasone—Dermatitis—Hydrocortisone—psoriasis	2.25e-06	5.54e-05	CcSEcCtD
Dexamethasone—ANXA1—Signaling Pathways—APOE—psoriasis	2.25e-06	0.000169	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—LEP—psoriasis	2.25e-06	0.000169	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—CYP2S1—psoriasis	2.24e-06	0.000169	CbGpPWpGaD
Dexamethasone—Headache—Hydrocortisone—psoriasis	2.24e-06	5.51e-05	CcSEcCtD
Dexamethasone—SLCO1A2—Metabolism—CARM1—psoriasis	2.23e-06	0.000168	CbGpPWpGaD
Dexamethasone—Dizziness—Triamcinolone—psoriasis	2.23e-06	5.47e-05	CcSEcCtD
Dexamethasone—Anaphylactic shock—Methotrexate—psoriasis	2.23e-06	5.47e-05	CcSEcCtD
Dexamethasone—Infection—Methotrexate—psoriasis	2.21e-06	5.43e-05	CcSEcCtD
Dexamethasone—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.2e-06	0.000165	CbGpPWpGaD
Dexamethasone—Feeling abnormal—Prednisone—psoriasis	2.19e-06	5.39e-05	CcSEcCtD
Dexamethasone—Asthenia—Betamethasone—psoriasis	2.19e-06	5.39e-05	CcSEcCtD
Dexamethasone—Nervous system disorder—Methotrexate—psoriasis	2.18e-06	5.36e-05	CcSEcCtD
Dexamethasone—Thrombocytopenia—Methotrexate—psoriasis	2.18e-06	5.35e-05	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Prednisone—psoriasis	2.18e-06	5.35e-05	CcSEcCtD
Dexamethasone—Nausea—Prednisolone—psoriasis	2.18e-06	5.35e-05	CcSEcCtD
Dexamethasone—CYP2D6—Metabolism—NDUFA5—psoriasis	2.17e-06	0.000163	CbGpPWpGaD
Dexamethasone—Pruritus—Betamethasone—psoriasis	2.16e-06	5.31e-05	CcSEcCtD
Dexamethasone—CYP19A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.16e-06	0.000163	CbGpPWpGaD
Dexamethasone—Hyperhidrosis—Methotrexate—psoriasis	2.15e-06	5.28e-05	CcSEcCtD
Dexamethasone—CYP2C9—Metabolism—NDUFA5—psoriasis	2.15e-06	0.000162	CbGpPWpGaD
Dexamethasone—Vomiting—Triamcinolone—psoriasis	2.14e-06	5.26e-05	CcSEcCtD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	2.14e-06	0.000161	CbGpPWpGaD
Dexamethasone—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	2.14e-06	0.000161	CbGpPWpGaD
Dexamethasone—Nausea—Hydrocortisone—psoriasis	2.13e-06	5.22e-05	CcSEcCtD
Dexamethasone—Rash—Triamcinolone—psoriasis	2.13e-06	5.22e-05	CcSEcCtD
Dexamethasone—Dermatitis—Triamcinolone—psoriasis	2.12e-06	5.21e-05	CcSEcCtD
Dexamethasone—Anorexia—Methotrexate—psoriasis	2.12e-06	5.21e-05	CcSEcCtD
Dexamethasone—Urticaria—Prednisone—psoriasis	2.12e-06	5.2e-05	CcSEcCtD
Dexamethasone—Headache—Triamcinolone—psoriasis	2.11e-06	5.19e-05	CcSEcCtD
Dexamethasone—Body temperature increased—Prednisone—psoriasis	2.11e-06	5.17e-05	CcSEcCtD
Dexamethasone—Abdominal pain—Prednisone—psoriasis	2.11e-06	5.17e-05	CcSEcCtD
Dexamethasone—ANXA1—Signaling Pathways—NFKBIA—psoriasis	2.09e-06	0.000158	CbGpPWpGaD
Dexamethasone—Diarrhoea—Betamethasone—psoriasis	2.09e-06	5.14e-05	CcSEcCtD
Dexamethasone—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.08e-06	0.000157	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.08e-06	0.000157	CbGpPWpGaD
Dexamethasone—Hypotension—Methotrexate—psoriasis	2.08e-06	5.11e-05	CcSEcCtD
Dexamethasone—CYP3A43—Metabolism—APOE—psoriasis	2.08e-06	0.000156	CbGpPWpGaD
Dexamethasone—PTGS2—Spinal Cord Injury—TP53—psoriasis	2.07e-06	0.000156	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	2.06e-06	0.000155	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—CAT—psoriasis	2.05e-06	0.000154	CbGpPWpGaD
Dexamethasone—NOS2—Hemostasis—TP53—psoriasis	2.04e-06	0.000153	CbGpPWpGaD
Dexamethasone—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	2.04e-06	0.000153	CbGpPWpGaD
Dexamethasone—Musculoskeletal discomfort—Methotrexate—psoriasis	2.03e-06	4.98e-05	CcSEcCtD
Dexamethasone—Dizziness—Betamethasone—psoriasis	2.02e-06	4.97e-05	CcSEcCtD
Dexamethasone—CYP19A1—Metabolism—CARM1—psoriasis	2.01e-06	0.000152	CbGpPWpGaD
Dexamethasone—Insomnia—Methotrexate—psoriasis	2.01e-06	4.94e-05	CcSEcCtD
Dexamethasone—NR3C1—SIDS Susceptibility Pathways—IL6—psoriasis	2e-06	0.000151	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—CYP2S1—psoriasis	2e-06	0.000151	CbGpPWpGaD
Dexamethasone—Nausea—Triamcinolone—psoriasis	2e-06	4.92e-05	CcSEcCtD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2e-06	0.000151	CbGpPWpGaD
Dexamethasone—Paraesthesia—Methotrexate—psoriasis	2e-06	4.91e-05	CcSEcCtD
Dexamethasone—NR3C1—Generic Transcription Pathway—PPARG—psoriasis	1.98e-06	0.000149	CbGpPWpGaD
Dexamethasone—Dyspepsia—Methotrexate—psoriasis	1.96e-06	4.81e-05	CcSEcCtD
Dexamethasone—ABCB1—Metabolism—CYP2S1—psoriasis	1.95e-06	0.000147	CbGpPWpGaD
Dexamethasone—Vomiting—Betamethasone—psoriasis	1.94e-06	4.78e-05	CcSEcCtD
Dexamethasone—CYP1B1—Metabolism—CARM1—psoriasis	1.94e-06	0.000146	CbGpPWpGaD
Dexamethasone—Decreased appetite—Methotrexate—psoriasis	1.93e-06	4.75e-05	CcSEcCtD
Dexamethasone—Rash—Betamethasone—psoriasis	1.93e-06	4.74e-05	CcSEcCtD
Dexamethasone—Dermatitis—Betamethasone—psoriasis	1.93e-06	4.73e-05	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Methotrexate—psoriasis	1.92e-06	4.72e-05	CcSEcCtD
Dexamethasone—Fatigue—Methotrexate—psoriasis	1.92e-06	4.71e-05	CcSEcCtD
Dexamethasone—Headache—Betamethasone—psoriasis	1.92e-06	4.71e-05	CcSEcCtD
Dexamethasone—Asthenia—Prednisone—psoriasis	1.91e-06	4.69e-05	CcSEcCtD
Dexamethasone—Pain—Methotrexate—psoriasis	1.9e-06	4.67e-05	CcSEcCtD
Dexamethasone—PTGS2—Spinal Cord Injury—IL6—psoriasis	1.9e-06	0.000143	CbGpPWpGaD
Dexamethasone—Pruritus—Prednisone—psoriasis	1.88e-06	4.63e-05	CcSEcCtD
Dexamethasone—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.88e-06	0.000142	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—CAT—psoriasis	1.87e-06	0.000141	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	1.87e-06	0.000141	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—CAT—psoriasis	1.85e-06	0.000139	CbGpPWpGaD
Dexamethasone—NOS2—Disease—TYK2—psoriasis	1.85e-06	0.000139	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—CYP2S1—psoriasis	1.84e-06	0.000139	CbGpPWpGaD
Dexamethasone—Feeling abnormal—Methotrexate—psoriasis	1.83e-06	4.5e-05	CcSEcCtD
Dexamethasone—CYP2C9—Metabolism—CYP2S1—psoriasis	1.83e-06	0.000137	CbGpPWpGaD
Dexamethasone—Diarrhoea—Prednisone—psoriasis	1.82e-06	4.48e-05	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Methotrexate—psoriasis	1.82e-06	4.47e-05	CcSEcCtD
Dexamethasone—Nausea—Betamethasone—psoriasis	1.82e-06	4.46e-05	CcSEcCtD
Dexamethasone—CYP1B1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.81e-06	0.000137	CbGpPWpGaD
Dexamethasone—CYP3A43—Metabolism—PPARG—psoriasis	1.81e-06	0.000136	CbGpPWpGaD
Dexamethasone—Urticaria—Methotrexate—psoriasis	1.77e-06	4.34e-05	CcSEcCtD
Dexamethasone—ABCG2—Metabolism—CARM1—psoriasis	1.77e-06	0.000133	CbGpPWpGaD
Dexamethasone—Dizziness—Prednisone—psoriasis	1.76e-06	4.33e-05	CcSEcCtD
Dexamethasone—Body temperature increased—Methotrexate—psoriasis	1.76e-06	4.32e-05	CcSEcCtD
Dexamethasone—Abdominal pain—Methotrexate—psoriasis	1.76e-06	4.32e-05	CcSEcCtD
Dexamethasone—CYP3A7—Metabolism—CARM1—psoriasis	1.75e-06	0.000132	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—TYK2—psoriasis	1.71e-06	0.000129	CbGpPWpGaD
Dexamethasone—Vomiting—Prednisone—psoriasis	1.69e-06	4.16e-05	CcSEcCtD
Dexamethasone—Rash—Prednisone—psoriasis	1.68e-06	4.12e-05	CcSEcCtD
Dexamethasone—Dermatitis—Prednisone—psoriasis	1.68e-06	4.12e-05	CcSEcCtD
Dexamethasone—NOS2—Disease—CD4—psoriasis	1.67e-06	0.000126	CbGpPWpGaD
Dexamethasone—Headache—Prednisone—psoriasis	1.67e-06	4.1e-05	CcSEcCtD
Dexamethasone—PGR—Signaling Pathways—SOCS1—psoriasis	1.66e-06	0.000125	CbGpPWpGaD
Dexamethasone—PGR—Gene Expression—PPARG—psoriasis	1.65e-06	0.000124	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—CAT—psoriasis	1.64e-06	0.000124	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—CARM1—psoriasis	1.6e-06	0.000121	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	1.6e-06	0.00012	CbGpPWpGaD
Dexamethasone—Asthenia—Methotrexate—psoriasis	1.6e-06	3.92e-05	CcSEcCtD
Dexamethasone—CYP17A1—Metabolism—APOE—psoriasis	1.59e-06	0.00012	CbGpPWpGaD
Dexamethasone—Nausea—Prednisone—psoriasis	1.58e-06	3.89e-05	CcSEcCtD
Dexamethasone—Pruritus—Methotrexate—psoriasis	1.57e-06	3.87e-05	CcSEcCtD
Dexamethasone—Diarrhoea—Methotrexate—psoriasis	1.52e-06	3.74e-05	CcSEcCtD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	1.52e-06	0.000114	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—CXCL8—psoriasis	1.49e-06	0.000112	CbGpPWpGaD
Dexamethasone—Dizziness—Methotrexate—psoriasis	1.47e-06	3.61e-05	CcSEcCtD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	1.46e-06	0.00011	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—APOE—psoriasis	1.45e-06	0.000109	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.44e-06	0.000109	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—APOE—psoriasis	1.44e-06	0.000108	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling by GPCR—IL6—psoriasis	1.42e-06	0.000107	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—NDUFA5—psoriasis	1.42e-06	0.000107	CbGpPWpGaD
Dexamethasone—Vomiting—Methotrexate—psoriasis	1.42e-06	3.48e-05	CcSEcCtD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	1.41e-06	0.000106	CbGpPWpGaD
Dexamethasone—Rash—Methotrexate—psoriasis	1.4e-06	3.45e-05	CcSEcCtD
Dexamethasone—Dermatitis—Methotrexate—psoriasis	1.4e-06	3.44e-05	CcSEcCtD
Dexamethasone—Headache—Methotrexate—psoriasis	1.39e-06	3.42e-05	CcSEcCtD
Dexamethasone—ANXA1—Signaling Pathways—JUN—psoriasis	1.39e-06	0.000104	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—PPARG—psoriasis	1.38e-06	0.000104	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—CAT—psoriasis	1.37e-06	0.000103	CbGpPWpGaD
Dexamethasone—NR3C1—Gene Expression—VDR—psoriasis	1.36e-06	0.000103	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—CARM1—psoriasis	1.35e-06	0.000101	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—NFKB1—psoriasis	1.34e-06	0.000101	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	1.32e-06	9.97e-05	CbGpPWpGaD
Dexamethasone—Nausea—Methotrexate—psoriasis	1.32e-06	3.25e-05	CcSEcCtD
Dexamethasone—CYP2B6—Metabolism—CARM1—psoriasis	1.29e-06	9.74e-05	CbGpPWpGaD
Dexamethasone—NOS2—Disease—STAT3—psoriasis	1.29e-06	9.73e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.28e-06	9.65e-05	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—APOE—psoriasis	1.28e-06	9.61e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—CARM1—psoriasis	1.27e-06	9.54e-05	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—PPARG—psoriasis	1.27e-06	9.53e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—CARM1—psoriasis	1.26e-06	9.52e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.26e-06	9.47e-05	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—PPARG—psoriasis	1.25e-06	9.44e-05	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—CAT—psoriasis	1.24e-06	9.33e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—LEP—psoriasis	1.23e-06	9.25e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—APOE—psoriasis	1.23e-06	9.25e-05	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—VEGFA—psoriasis	1.21e-06	9.13e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—CYP2S1—psoriasis	1.2e-06	9.06e-05	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—STAT3—psoriasis	1.2e-06	9.04e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—CARM1—psoriasis	1.19e-06	9e-05	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—CAT—psoriasis	1.19e-06	8.98e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.18e-06	8.85e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—NFKBIA—psoriasis	1.14e-06	8.62e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	1.13e-06	8.54e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.12e-06	8.41e-05	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—PPARG—psoriasis	1.11e-06	8.37e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—CARM1—psoriasis	1.1e-06	8.25e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—CAT—psoriasis	1.09e-06	8.17e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—CAT—psoriasis	1.08e-06	8.1e-05	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—APOE—psoriasis	1.07e-06	8.02e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.05e-06	7.9e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.02e-06	7.71e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	1e-06	7.53e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—CAT—psoriasis	9.86e-07	7.43e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—CARM1—psoriasis	9.78e-07	7.36e-05	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—APOE—psoriasis	9.63e-07	7.25e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	9.57e-07	7.2e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—CARM1—psoriasis	9.54e-07	7.18e-05	CbGpPWpGaD
Dexamethasone—NR3C1—Gene Expression—PPARG—psoriasis	9.51e-07	7.16e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—TYK2—psoriasis	9.37e-07	7.06e-05	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—PPARG—psoriasis	9.28e-07	6.99e-05	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—APOE—psoriasis	9.27e-07	6.98e-05	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—TP53—psoriasis	9.16e-07	6.9e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	9.14e-07	6.88e-05	CbGpPWpGaD
Dexamethasone—NOS2—Disease—IL6—psoriasis	9.03e-07	6.8e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—CARM1—psoriasis	8.99e-07	6.77e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—CARM1—psoriasis	8.92e-07	6.71e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—APOE—psoriasis	8.44e-07	6.35e-05	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—PPARG—psoriasis	8.39e-07	6.31e-05	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—IL6—psoriasis	8.39e-07	6.31e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—APOE—psoriasis	8.36e-07	6.3e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	8.33e-07	6.27e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—CAT—psoriasis	8.28e-07	6.23e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—HLA-A—psoriasis	8.23e-07	6.2e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—CXCL8—psoriasis	8.16e-07	6.14e-05	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—PPARG—psoriasis	8.08e-07	6.08e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—CAT—psoriasis	7.96e-07	5.99e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—CAT—psoriasis	7.8e-07	5.87e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—CAT—psoriasis	7.78e-07	5.86e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—APOE—psoriasis	7.68e-07	5.78e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—APOE—psoriasis	7.66e-07	5.77e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—JUN—psoriasis	7.59e-07	5.71e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—CAT—psoriasis	7.35e-07	5.53e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—PPARG—psoriasis	7.35e-07	5.53e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—NFKB1—psoriasis	7.3e-07	5.5e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—PPARG—psoriasis	7.28e-07	5.48e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—NOS2—psoriasis	7.16e-07	5.39e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—CAT—psoriasis	6.74e-07	5.07e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—PPARG—psoriasis	6.68e-07	5.03e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—VEGFA—psoriasis	6.63e-07	4.99e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—STAT3—psoriasis	6.56e-07	4.94e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—APOE—psoriasis	6.43e-07	4.84e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—APOE—psoriasis	6.18e-07	4.66e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—APOE—psoriasis	6.06e-07	4.56e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—APOE—psoriasis	6.04e-07	4.55e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—CAT—psoriasis	6.01e-07	4.53e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—CARM1—psoriasis	5.88e-07	4.43e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—CAT—psoriasis	5.87e-07	4.42e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—TYK2—psoriasis	5.86e-07	4.41e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—APOE—psoriasis	5.71e-07	4.3e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—PPARG—psoriasis	5.6e-07	4.22e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—CAT—psoriasis	5.53e-07	4.16e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—CAT—psoriasis	5.48e-07	4.13e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PPARG—psoriasis	5.39e-07	4.06e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—CD4—psoriasis	5.3e-07	3.99e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PPARG—psoriasis	5.28e-07	3.97e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PPARG—psoriasis	5.26e-07	3.96e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—APOE—psoriasis	5.24e-07	3.94e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—TP53—psoriasis	5.01e-07	3.77e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PPARG—psoriasis	4.97e-07	3.74e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—APOE—psoriasis	4.67e-07	3.52e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—IL6—psoriasis	4.58e-07	3.45e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—APOE—psoriasis	4.56e-07	3.43e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PPARG—psoriasis	4.56e-07	3.43e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—APOE—psoriasis	4.3e-07	3.24e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—APOE—psoriasis	4.26e-07	3.21e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—STAT3—psoriasis	4.11e-07	3.09e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PPARG—psoriasis	4.07e-07	3.06e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PPARG—psoriasis	3.97e-07	2.99e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PPARG—psoriasis	3.74e-07	2.82e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PPARG—psoriasis	3.71e-07	2.79e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—CAT—psoriasis	3.62e-07	2.72e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—IL6—psoriasis	2.87e-07	2.16e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—APOE—psoriasis	2.81e-07	2.12e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PPARG—psoriasis	2.45e-07	1.84e-05	CbGpPWpGaD
